To Be or Not to Be: Benefits and Challenges of 340B

<p>Dylan Kosaski, PharmD (<a href='https://twitter.com/Dylan_Kosaski'>@Dylan_Kosaski</a>) identifies the purpose of 340B and the impact on health care costs, evaluates the role of 340B contract pharmacies and reviews challenges facing the 340B program and potential consequences.</p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>